drug

Fazaclo

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Manhattan Psychiatric Center
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
NCT00501618Phase 4Completed

KOLs & investigators

2
Jean-Pierre Lindenmayer, MDKOL score 5
Saurabh Kaushik, MDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Manhattan Psychiatric Center
company
trial
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Jean-Pierre Lindenmayer, MD
KOL score 5
person
Saurabh Kaushik, MD
KOL score 5
person